immunosuppressive

(redirected from immunosuppressives)
Also found in: Dictionary, Thesaurus, Medical.

immunosuppressive

[¦im·yə·nō·sə′pres·iv]
(pharmacology)
Any drug or agent used to suppress antibody production.
References in periodicals archive ?
Many therapies for autoimmune disease focus on immunosuppressive agents, which are associated with an increased risk of infection.
Following exclusion of non--SLE-related problems, glucocorticoids and immunosuppressives are indicated for neuropsychiatric manifestations that reflect an immune or inflammatory process, including acute confusional state, aseptic meningitis, myelitis, psychosis, and cranial and peripheral neuropathies.
In general, the group recommended that glucocorticoids, immunosuppressives, and other SLE-specific treatments be used as adjuncts to standard neuropsychiatric therapies, not as replacements for them.
TDM plays a key role in helping clinicians maintain blood and plasma levels of immunosuppressive drugs within their respective therapeutic ranges.
The immunosuppressive drugs that children who have received organ transplantation must take lifelong to suppress their own immune reaction to transplants are potent and often have serious side effects.
Researchers from the National Cancer Institute have isolated a compound from the urine of pregnant women that has immunosuppressive capabilities.
Trends in the Use of Immunosuppressives in Specific Organs
However, it is now apparent that the bill- the Medicare Prescription Drug, Improvement, and Modernization Act (MMA)--could be life threatening to the 84,000 transplant recipients who are Medicare beneficiaries and may not be able to afford the immunosuppressive drugs needed to stay alive.
Patients with Crohn's disease respond to treatment with infliximab more often or for longer periods when they concurrently take another immunosuppressive therapy and do not smoke, reported Mansour A.
As expected, the US Congress voted to extend Medicare coverage of immunosuppressive medications for certain organ transplant recipients.
More than half of all members of the US Senate and House of Representatives have become co-sponsors of legislation that would end time the limitation on Medicare coverage of immunosuppressive drugs needed by transplant recipients, according to the National Kidney Foundation (NKF).
The company will continue its strategy to demonstrate the potential of its small molecule immunosuppressives in in vivo disease models and to show safety and efficacy in human clinical trials for its AIDS programs.